These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 33572396)

  • 1. Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response.
    Toffoli EC; Sheikhi A; Höppner YD; de Kok P; Yazdanpanah-Samani M; Spanholtz J; Verheul HMW; van der Vliet HJ; de Gruijl TD
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK Cell-Fc Receptors Advance Tumor Immunotherapy.
    Sanseviero E
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31614774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell-based therapeutics for lung cancer.
    Pockley AG; Vaupel P; Multhoff G
    Expert Opin Biol Ther; 2020 Jan; 20(1):23-33. PubMed ID: 31714156
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
    Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
    J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.
    Bernard NF; Kiani Z; Tremblay-McLean A; Kant SA; Leeks CE; Dupuy FP
    Front Immunol; 2017; 8():1033. PubMed ID: 28883824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of Natural killer cells in oncolytic virotherapy.
    Bhat R; Rommelaere J
    Immunotargets Ther; 2015; 4():65-77. PubMed ID: 27471713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab.
    Fujii R; Schlom J; Hodge JW
    J Neurosurg; 2018 May; 128(5):1419-1427. PubMed ID: 28753113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies.
    Shevtsov M; Multhoff G
    Front Immunol; 2016; 7():492. PubMed ID: 27891129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
    Kim N; Kim HS
    Front Immunol; 2018; 9():2041. PubMed ID: 30250471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches.
    Carotta S
    Front Immunol; 2016; 7():152. PubMed ID: 27148271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.
    Friedman J; Morisada M; Sun L; Moore EC; Padget M; Hodge JW; Schlom J; Gameiro SR; Allen CT
    J Immunother Cancer; 2018 Jun; 6(1):59. PubMed ID: 29925431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.
    Dahlberg CI; Sarhan D; Chrobok M; Duru AD; Alici E
    Front Immunol; 2015; 6():605. PubMed ID: 26648934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the "missing self" hypothesis to adaptive NK cells: Insights of NK cell-mediated effector functions in immune surveillance.
    Cruz-Muñoz ME; Valenzuela-Vázquez L; Sánchez-Herrera J; Santa-Olalla Tapia J
    J Leukoc Biol; 2019 May; 105(5):955-971. PubMed ID: 30848847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions.
    Wang Z; Guan D; Wang S; Chai LYA; Xu S; Lam KP
    Front Immunol; 2020; 11():202. PubMed ID: 32153568
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Desimio MG; Giuliani E; Ferraro AS; Adorno G; Doria M
    Front Immunol; 2018; 9():1514. PubMed ID: 30008723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natural killer (NK) cell and immunotherapy].
    Iino T; Takaishi S
    Nihon Rinsho; 2017 Feb; 75(2):306-311. PubMed ID: 30562869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.
    Davis ZB; Vallera DA; Miller JS; Felices M
    Semin Immunol; 2017 Jun; 31():64-75. PubMed ID: 28882429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection.
    Rajalingam R
    Front Immunol; 2016; 7():585. PubMed ID: 28066408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
    Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
    Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.